Deal facts
- Buyer
- DocGo Inc.
- Target
- Hicuity Health, Inc.
- Deal value
- Not disclosed
- Announced
- 16 August 2026
- Status
- In review
- Sector
- Healthcare
- Country
- United States
- Consideration
- cash
Sources
DocGo Inc. has agreed to acquire Hicuity Health, Inc. in a strategic transaction. The deal was announced on 16 August 2026. Both the buyer and the target are based in the United States. The acquisition is situated within the healthcare sector. The consideration for the purchase is structured as cash. The specific financial value of the transaction has not been disclosed. There is no reported completion date for the deal. The current status of the transaction is in review. No further details regarding the specific terms or conditions beyond the cash consideration have been provided. The parties have not issued additional statements regarding the strategic rationale or operational integration plans. The transaction remains pending finalisation. Regulatory or internal approvals may still be required to close the deal. The exact timeline for completion is currently unknown. This acquisition represents a move by DocGo Inc. to expand its portfolio within the healthcare industry. The lack of disclosed valuation figures prevents a direct assessment of the premium paid. The deal structure is straightforward, involving a single cash payment. Both entities operate in the same country, simplifying certain aspects of the integration process. The announcement date marks the formal public disclosure of the agreement.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CMA invitation to comment
DocGo Inc. M&A filing involving Hicuity Health, Inc.
Introductory Note. As previously disclosed, on August 16, 2026, DocGo Inc., a Delaware corporation ("DocGo" or the "Company"), Ambulnz Holdings, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company ("Ambulnz"), HH Merger Sub, LLC, a Delaware limited liability company and a wholly owned subsidiary of Ambulnz ("MergerCo"), Hicuity Health, Inc., a Delaware corporatio
Source
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Circle Health Holdings Limited to acquire CHC Healthcare Holdings Limited
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…
- Buyer
- Circle Health Holdings Limited
- Target
- CHC Healthcare Holdings Limited
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Cronos Group Inc. to acquire CanAdelaar B.V.
Cronos Group Inc. has agreed to acquire CanAdelaar B.V. in a strategic acquisition within the healthcare sector. The Canadian buyer will purchase the Dutch target for a…
- Buyer
- Cronos Group Inc.
- Target
- CanAdelaar B.V.
- Deal value
- EUR 57,500,000
- Deal type
- strategic acquisition
Alaunos Therapeutics, Inc. to acquire Velaris Therapeutics, Inc.
Alaunos Therapeutics, Inc. has agreed to acquire Velaris Therapeutics, Inc. in a strategic acquisition. The transaction was announced on 13 October 2026 and was complete…
- Buyer
- Alaunos Therapeutics, Inc.
- Target
- Velaris Therapeutics, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
STERIS Corporation to acquire Xodus Medical, Inc.
STERIS Corporation has agreed to acquire Xodus Medical, Inc. in a strategic transaction valued at two billion US dollars. The healthcare deal was announced on 11 October…
- Buyer
- STERIS Corporation
- Target
- Xodus Medical, Inc.
- Deal value
- USD 2,100,000,000
- Deal type
- strategic acquisition
Hepion Pharmaceuticals, Inc. to acquire Gravitas Life Sciences, LLC
Hepion Pharmaceuticals, Inc. has agreed to acquire Gravitas Life Sciences, LLC in a strategic acquisition. The transaction, valued at 4.25 million US dollars, was comple…
- Buyer
- Hepion Pharmaceuticals, Inc.
- Target
- Gravitas Life Sciences, LLC
- Deal value
- USD 4,250,000
- Deal type
- strategic acquisition
Buyer history
DocGo Inc.
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive